Trial Profile

The CATS study is a single center translational prospective study on extensive small cell lung cancer patients receiving atezolizumab, carboplatin and etoposide investigating the predictive role of circulating B.

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 12 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Dec 2023 New trial record
24 Oct 2023 Results (n=20; At data cut-off 1 April 2023) assessing circulating biomarkers in extensive small cell lung cancer patients, presented at the 48th European Society for Medical Oncology Congress.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com